Clinical Trial Update: Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Clopidogrel [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study to evaluate the effect of ISIS 681257 on clopidogrel in patients with elevated lipoprotein(a) and cardiovascular diseases. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Elevated Lipoprotein

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• ISIS 681257

Snippet

Sponsor: Akcea Therapeutics | Conditions: Elevated Lipoprotein(a), Cardiovascular Diseases | Phase 1 | Status: COMPLETED